Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-12

FDA Approved: TRI FEMYNOR — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved the original application for TRI FEMYNOR (norgestimate and ethinyl estradiol) manufactured by Amneal Pharmaceuticals NY LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRI FEMYNOR (NORGESTIMATE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for TRI FEMYNOR (NORGESTIMATE AND ETHINYL ESTRADIOL)